Cargando…

Diet Quality and Dietary Inflammatory Index in Dutch Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients

Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) share common culprit foods and potential pathophysiological factors. However, how diet may contribute to disease course and whether this differs between both entities is unclear. We therefore investigated the association of dietary...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Graaf, Marlijne C. G., Spooren, Corinne E. G. M., Hendrix, Evelien M. B., Hesselink, Martine A. M., Feskens, Edith J. M., Smolinska, Agnieszka, Keszthelyi, Daniel, Pierik, Marieke J., Mujagic, Zlatan, Jonkers, Daisy M. A. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101333/ https://www.ncbi.nlm.nih.gov/pubmed/35565912 http://dx.doi.org/10.3390/nu14091945

Ejemplares similares

The Intake of Dicarbonyls and Advanced Glycation Endproducts as Part of the Habitual Diet Is Not Associated with Intestinal Inflammation in Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients
por: de Graaf, Marlijne C. G., et al.
Publicado: (2022)

Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome
por: Weerts, Zsa Zsa R. M., et al.
Publicado: (2019)

Classic drugs in the time of new drugs: real‐world, long‐term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease
por: Rezazadeh Ardabili, Ashkan, et al.
Publicado: (2022)

A novel biomarker panel for irritable bowel syndrome and the application in the general population
por: Mujagic, Zlatan, et al.
Publicado: (2016)

Examining the optimal cutoff values of HADS, PHQ‐9 and GAD‐7 as screening instruments for depression and anxiety in irritable bowel syndrome
por: Snijkers, Johanna T. W., et al.
Publicado: (2021)

Intestinal barrier function is maintained with aging – a comprehensive study in healthy subjects and irritable bowel syndrome patients
por: Wilms, Ellen, et al.
Publicado: (2020)

Integrated fecal microbiome–metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome
por: Mujagic, Zlatan, et al.
Publicado: (2022)

Age-Related Decrease in Abdominal Pain and Associated Structural- and Functional Mechanisms: An Exploratory Study in Healthy Individuals and Irritable Bowel Syndrome Patients
por: Beckers, Abraham B., et al.
Publicado: (2021)

Development and Validation of a Remote Monitoring Tool for Assessment of Mild, Moderate, and Severe Infections in Inflammatory Bowel Disease
por: Rezazadeh Ardabili, Ashkan, et al.
Publicado: (2023)

Remote Monitoring of Inflammatory Bowel Disease: What Kind of Patient-Reported Questionnaires Should We Use?
por: Rezazadeh Ardabili, Ashkan, et al.
Publicado: (2020)

Patient-Specific Stress–Abdominal Pain Interaction in Irritable Bowel Syndrome: An Exploratory Experience Sampling Method Study
por: Vork, Lisa, et al.
Publicado: (2020)

Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease
por: Spekhorst, Lieke M, et al.
Publicado: (2017)

Scoping review on health-related physical fitness in patients with inflammatory bowel disease: Assessment, interventions, and future directions
por: Demers, Karlijn, et al.
Publicado: (2023)

Irritable bowel syndrome, inflammatory bowel disease and the microbiome
por: Major, Giles, et al.
Publicado: (2014)

Volatomics in inflammatory bowel disease and irritable bowel syndrome
por: Van Malderen, Kathleen, et al.
Publicado: (2020)

Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational Study
por: Weerts, Zsa Zsa R M, et al.
Publicado: (2020)

Psychological Interventions for Irritable Bowel Syndrome and Inflammatory Bowel Diseases
por: Ballou, Sarah, et al.
Publicado: (2017)

Interoceptive Abilities in Inflammatory Bowel Diseases and Irritable Bowel Syndrome
por: Fournier, Alicia, et al.
Publicado: (2020)

Severe COVID-19 in inflammatory bowel disease patients in a population-based setting
por: Creemers, Rob H., et al.
Publicado: (2021)

Correction: Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational Study
por: Weerts, Zsa Zsa R M, et al.
Publicado: (2021)

A trial‐based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome
por: Weerts, Zsa Zsa R. M., et al.
Publicado: (2021)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Cui, Xiufang, et al.
Publicado: (2021)

Efficacy of a Digital Personalized Elimination Diet for the Self-Management of Irritable Bowel Syndrome and Comorbid Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Jactel, Samuel N., et al.
Publicado: (2022)

Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome
por: Porter, Chad K, et al.
Publicado: (2012)

Symptomatology of irritable bowel syndrome and inflammatory bowel disease during the menstrual cycle
por: Bharadwaj, Shishira, et al.
Publicado: (2015)

Experiences of healing therapy in patients with irritable bowel syndrome and inflammatory bowel disease
por: Soundy, Andrew, et al.
Publicado: (2015)

Are Probiotics or Prebiotics Useful in Pediatric Irritable Bowel Syndrome or Inflammatory Bowel Disease?
por: Guandalini, Stefano
Publicado: (2014)

Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases
por: Ceuleers, Hannah, et al.
Publicado: (2016)

Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Lo Presti, Alessandra, et al.
Publicado: (2019)

Proinflammatory cytokines in irritable bowel syndrome: a comparison with inflammatory bowel disease
por: Mitselou, Antigony, et al.
Publicado: (2020)

(Poly)phenols in Inflammatory Bowel Disease and Irritable Bowel Syndrome: A Review
por: Hagan, Marilyn, et al.
Publicado: (2021)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Erratum to: Experiences of healing therapy in patients with irritable bowel syndrome and inflammatory bowel disease
por: Soundy, Andrew, et al.
Publicado: (2015)

Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease
por: Pedersen, Natalia, et al.
Publicado: (2017)

Do Patients’ and Physicians’ Perspectives Differ on Preferences for Irritable Bowel Syndrome Treatment?
por: Sturkenboom, Rosel, et al.
Publicado: (2022)

Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease
por: Becker, Heike E. F., et al.
Publicado: (2023)

Irritable bowel syndrome - An inflammatory disease involving mast cells
por: Philpott, Hamish, et al.
Publicado: (2011)

Irritable Inflammatory Bowel Syndrome as a Distinct Disease Entity
por: Oh, Jung Hwan
Publicado: (2016)

Targeted therapy of irritable bowel syndrome with anti-inflammatory cytokines
por: Kumar, Sunil, et al.
Publicado: (2021)

Genetic and phenotypic diversity of fecal Candida albicans strains in irritable bowel syndrome
por: van Thiel, Isabelle A. M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3rvoaeo5c4lt8bvfiujh70ps17